Grottaferrata, Italy

Giovanni Monteleone

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 1.2

ph-index = 13

Forward Citations = 364(Granted Patents)


Location History:

  • Rome, IT (2010 - 2018)
  • Grottaferrata, IT (2016 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Giovanni Monteleone: Innovator in Intestinal Fibrosis Treatment

Introduction

Giovanni Monteleone, based in Grottaferrata, Italy, is an accomplished inventor with a remarkable portfolio of 23 patents. His innovative work primarily focuses on therapies addressing intestinal fibrosis, which is a significant concern in gastrointestinal health.

Latest Patents

Among his latest patents, Monteleone has developed methods for treating intestinal fibrosis using SMAD7 inhibition. This invention details techniques for treating, preventing, or managing intestinal fibrosis by inhibiting SMAD7. It also encompasses methods to monitor treatment effectiveness through the use of a SMAD7 antisense oligonucleotide. In addition, these methods facilitate the regulation of SMAD7 antisense oligonucleotide treatment based on analyses of levels of Transforming Growth Factor-β (TGF-β), α-Smooth Muscle Actin (a-SMA), and phosphorylated Mothers Against Decapentaplegic Homolog 3 (p-SMAD3) levels. Furthermore, his inventions include antisense oligonucleotidic sequences against SMAD7, which are suitably modified for use as therapeutic agents in the medical field, particularly in treating chronic inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

Career Highlights

Giovanni Monteleone has made significant contributions to the pharmaceutical landscape through his work, including positions at several prominent companies. He has worked with Nogra Pharma Limited and Giuliani International Limited, where he played integral roles in advancing therapeutic innovations.

Collaborations

Throughout his career, Monteleone has collaborated with prominent colleagues in the field. Notable collaborators include Salvatore Bellinvia and Francesca Viti, with whom he has shared ideas and expertise to further the development of groundbreaking medical therapies.

Conclusion

In summary, Giovanni Monteleone stands out as a notable inventor in the field of intestinal health with a strong focus on the potential of SMAD7 inhibition for treating intestinal fibrosis. His numerous patents and collaborations exemplify his commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…